Post-close erosion is the silent killer
The founder slows down, referring ODs hedge, tenured staff churn — and volume drifts a few points a quarter while everyone's focused on integration. The multiple you paid assumed none of that.
Every ophthalmology deal is priced on momentum — the founder's reputation, the OD referral base, the surgical volume. Post-close, all three start eroding the moment nobody defends them. Denali is the growth partner PE-backed eye care platforms bring in after the ink dries: we protect what you paid for, build the organic growth the model assumes, and report it in the units your IC actually uses — cost per surgery by location and premium mix by surgeon.
An acquired eye care practice isn't a machine you bought — it's a set of relationships you're renting from the past: the founder's name, the ODs who trust him, the team that answers his phones. Left undefended, all of it erodes quietly against the model. Defended and built on, it compounds.
The founder slows down, referring ODs hedge, tenured staff churn — and volume drifts a few points a quarter while everyone's focused on integration. The multiple you paid assumed none of that.
Multiple arbitrage built the platform; organic growth is what the next buyer pays up for. Same-store volume and premium IOL mix are the levers — a few mix points per location move the mark more than any add-on.
Nothing spooks a referring optometrist like an acquisition announcement. Referral channels that took decades to build can drift to competitors in a quarter — unless outreach is part of the integration plan from day one.
Every deal model assumes the acquired practice keeps performing. It won't — not on its own. The founder's name fades, the ODs hedge, the phones get sloppy. Our job is to make sure the momentum you paid for compounds instead of decays — and to prove it, surgeon by surgeon, on a scoreboard your IC can read.
It's the lesson our founder proved as a refractive coordinator — 15–20 cases a month to 127 in 60 days with zero change to the advertising: conversion multiplies everything. At one practice that's a win; across a platform, it's the model.
Unified scripts, empathy-first answering, and call scoring across every location — with booking rates monitored per office. Our ophthalmology phone training, deployed platform-wide.
The Rainmaker System, standardized: consult flow, premium IOL presentation, and objection handling trained across every counselor — so your best converter's numbers stop being an outlier. See the sales training →
Platform hub plus real location pages and surgeon bios — unique content, local proof, and legacy-brand SEO preserved — with Business Profiles managed and tracking installed everywhere.
Localized campaigns with per-location budgets, every dollar attributed to the office and service line that spent it. Same spend, dramatically better math.
From the day the deal closes to the day the platform trades, each stage of the hold has its own growth problem — and a platform running multiple acquisitions lives in several stages at once. We bring a play for each.
The moment: The deal just closed on a practice whose surgeon spent thirty years building a name, a review base, and an OD referral network — the assets the multiple was priced on. The next hundred days decide whether they compound or quietly walk out the door while everyone is busy with payroll integration.
The moment: The rolled-over founder is on a three-year runway to the exit ramp — and the practice's demand is still attached to his name. If patient and OD loyalty doesn't transfer to the associates before he winds down, the platform inherits a building instead of a practice.
The moment: One location consistently trails the platform — fewer consults, weaker conversion, higher acquisition cost — and the ops review can't say why. The deal team suspects the market; the office suspects the marketing; the answer is hiding in data nobody has isolated.
The moment: The hold period's core work: the model assumes same-store growth, and the leverage isn't more patients — it's what each surgical conversation produces. Premium IOL mix, refractive volume, and cash-pay lines are where EBITDA actually moves.
The moment: Eighteen months from a process, and the question shifts: can the platform prove its growth is a system, not a founder's residue? Buyers pay up for repeatable, attributable organic growth — and discount everything they can't verify in diligence.
Most platform marketing reports arrive as one blended number — and blended numbers are where the thesis quietly leaks. The satellite missing a third of its calls, the counselor whose premium mix trails the platform by twenty points, the acquired market whose OD referrals have been drifting since close: invisible in the average, obvious in the breakdown.
We report the way the model is built: by location, by surgeon, by service line. Every campaign, call, consult, and surgery attributed to where it happened — rolled up for the IC and the board, broken out for the operators — so marketing stops being a cost line and starts reading like what it is: the value-creation engine.
A platform mid-hold is never in just one mode — one market is integrating, another is transitioning its founder, a third is prepping for the process. Diagnose each, run the right play for its stage, and measure them all on one scoreboard.
Local visibility, surgeon-brand equity, phones, counselor conversion, and OD referral health — scored location by location.
Phones trained, counselors standardized on the Rainmaker System, real location and surgeon pages built, attribution installed.
Per-location budgets across ads, local SEO, video, and OD outreach — each market fighting its own battle, well-armed.
One scoreboard for the board, market-level detail for operators, and budget that follows the math every month.
Location-budgeted campaigns across refractive, cataract, and cash-pay lines, with per-office call tracking.
Per-location optimization, Business Profile management, and SEO-safe acquisition migrations that keep the equity you bought.
OD referral protection through integration and growth into new territories — relationship programs, CE events, and co-management support.
Unified dashboards — cost per surgery by location, premium mix by surgeon, referral volume by source.
Surgeon-led video, patient stories, and pre-consult education content that lifts premium conversion — produced in-house.
The Rainmaker System deployed platform-wide — phone scripts, consult flow, and premium IOL presentation, scored monthly.
Representative outcomes from multi-location ophthalmology engagements. Real numbers available on a call.
Organically, market by market: protect the acquired assets first — surgeon reputations, rankings, reviews, and OD referral channels — then build same-store growth through premium IOL conversion, service-line expansion, and localized demand campaigns with per-location budgets. The platform scales centrally; the patients and referrals are won locally, doctor by doctor. Attribution ties it together, reporting cost per surgery by location and premium mix by surgeon — the units the value-creation model already uses.
It's a market-by-market decision, not a policy. Where the surgeon's name carries decades of patient trust and OD relationships, an endorsed hybrid — legacy brand, "part of" the platform — usually preserves the most value; where the acquired brand is weak or the surgeon is retiring, a faster transition makes sense. What should never vary is the execution: full redirect mapping, Business Profile transitions that keep the review history, and messaging sequenced so patient retention leads the sign change.
By reaching the referral base before the rumor mill does. Day-one outreach reassures referring optometrists on what actually matters to them: co-management continuity, patient access, the same surgeons, and respect for their patient relationships. From there, a sustained program — practice visits, CE events, co-management support, and a dedicated outreach role — turns a defensive play into channel growth. See our optometric outreach program →
Mix is a conversation problem, and it scales through standardization: baseline premium conversion by counselor and surgeon, train the presentation — outcomes first, clear package tiers, financing normalized — support it with pre-consult patient education video, and track the movement monthly on the platform scoreboard. Your best counselor's numbers prove what's possible; the system's job is making them the platform average. See the Rainmaker System →
Strategy and buying power centralize; budgets allocate per market. Each location faces different competition, capacity, and stage — a flat split starves growth markets and overfeeds mature ones. With per-location attribution in place, allocation becomes a monthly math decision: dollars flow to the markets and service lines where cost per surgery earns it, and the board sees exactly why.
Whatever you've built before he leaves. Demand attached to a retiring surgeon's name doesn't transfer on its own — it has to be deliberately moved to the associates through elevation campaigns, founder-endorsed handoff content, and OD outreach that re-anchors referrals to the practice rather than the person. Start two to three years out and the transition is a non-event; start after the retirement announcement and you're marketing a building.
The scoreboard the model runs on: cost per consult and per surgery by location, premium IOL mix by surgeon and counselor, phone booking rates by office, and OD referral volume by source — rolled up for the board, broken out for operators, delivered monthly. Marketing reported in the same units as the investment thesis is what turns it from a cost line into a value-creation lever.
Buyers pay up for growth they can verify and systems they can keep. We harden attribution so organic growth survives a quality-of-earnings review, document the growth engine — playbooks, training systems, dashboards — as transferable infrastructure rather than tribal knowledge, and build same-store and mix momentum deliberately into the exit window, when each point is worth the most. The result is a marketing data room a buyer's advisors can work with instead of discount.
Book a no-pitch strategy call, or request a portfolio audit — we'll show you which markets are compounding, where the thesis is leaking, and what the next dollar should buy.